An injectable version of this drug is in phase 3 clinical trials, while an oral version completed a phase 2 trial last year
GLP-1 Agonist Use Overview GLP-1 agonists are FDA-approved medications for managing Type 2 diabetes (T2D) because they lower blood sugar levels (15)(23)
Giffi evaluates both during your first appointment
Ensuring adequate hydration and not skipping meals entirely can help
This includes large language models, machine learning models, neural networks, generative systems, retrieval-augmented systems, and any software that ingests content to produce outputs
GI side effects: Nausea, bloating, and stomach discomfort are common early in treatment